Healthcare

Shenzhen Boya Gene Technology Co., Ltd. is a biotechnology startup focused on the research and clinical translation of gene therapy drugs, with a focus on chronic diseases and functional degenerative diseases that seriously affect the health of a large number of elderly people. Our gene drug uses adenovirus associated virus (AAV) as a delivery technology.

Shenzhen Weikesen Biopharmaceutical Technology Co., Ltd. was founded in March 2022, jointly established by Zhengzhou Weirui Biotechnology Co., Ltd. and investment funds, mainly engaged in the research and development of anti-tumor/antiviral immune drugs/therapeutic vaccines.

Shenzhen Zhuoqiao Medical Immunology Technology Co., Ltd. is a brand under the umbrella of Shenzhen Zhuoqiao Medical Immunology Technology Co., Ltd. Established in 2025, it is composed of several frontline R&D personnel with over ten years of experience in the CGT drug industry. There are two main businesses: (1) research and development of high-throughput flow electric conversion equipment; (2) Serving hospitals and enterprises, we can provide mature and clinically applicable next-generation CGT cell drug preparation solutions.

Shenzhen Pruqi Biotechnology Co., Ltd. (referred to as "Pruqi Biotechnology") was established in 2024 and is an innovative biotechnology enterprise focusing on the field of pet health. Its headquarters is located in Guangming District, Shenzhen. Our mission is to empower pet health through technological innovation, and we are committed to becoming a leader in the field of pet bioproducts.

Shenzhen Zhizi Gene Technology Co., Ltd. is a cell technology research and development company, mainly engaged in: cell technology research and application; Research and development of biochemical product technology; Research and development of biopesticide technology; Research and development of fermentation process optimization technology; Medical research and experimental development; Engineering and technical research and experimental development; Natural science research and experimental development; Development of human genetic diagnosis and treatment technology; Development and application of human stem cell technology.